» Articles » PMID: 25246148

Altered Serum Cytokine Signature in Common Variable Immunodeficiency

Overview
Journal J Clin Immunol
Publisher Springer
Date 2014 Sep 24
PMID 25246148
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Common variable immunodeficiency (CVID) is the most frequent form of primary symptomatic hypogammaglobulinemia. CVID patients display a number of abnormalities in lymphocyte subpopulations including chronic T-cell activation and decreased numbers of circulating CD4(+) T cells and NK cells. We and others have recently shown that CVID is associated with increased concentration of soluble CD14 (sCD14) and other factors indicating limited microbial translocation.

Methods: To address the mechanisms of chronic immune activation in CVID, we performed a detailed analysis of cytokine serum levels in 36 patients with CVID, 52 patients with selective IgA deficiency (IgAD), and 56 healthy volunteers.

Results: We show that CVID is associated with elevated serum levels of CXCL-10/IP-10, IL-1R antagonist, TNF-α, IL-10, IL-12 (p40), CCL-2/MCP-1, G-CSF, and CCL-11/eotaxin. The detected cytokine signature is consistent with an ongoing activation of cells of myeloid lineage. In contrast, the levels of cytokines typically produced by CD4(+) T helper cells of Th1 (IFN-γ, IL-2), Th2 (IL-9, IL-13), and Th17 (IL-17) subtypes were suppressed in CVID patients compared to healthy donors.

Conclusions: Presented data suggest that the altered cytokine profile observed in patients with CVID may be attributed to the activation of monocyte-macrophage and granulocyte lineages, possibly driven by the translocation of bacterial components across the gastrointestinal or respiratory tracts mucosal barrier.

Citing Articles

Differential Diagnosis: Hepatic Complications in Inborn Errors of Immunity.

Zinser E, Tan K, Kim D, OBrien R, Winstanley A, Yong P J Clin Med. 2023; 12(23).

PMID: 38068532 PMC: 10707526. DOI: 10.3390/jcm12237480.


Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID).

Poto R, Pecoraro A, Ferrara A, Punziano A, Lagnese G, Messuri C Front Immunol. 2023; 14:1257398.

PMID: 37841257 PMC: 10568625. DOI: 10.3389/fimmu.2023.1257398.


Clinical and immunological characterisation of patients with common variable immunodeficiency related immune thrombocytopenia.

Somasundaram N, Meyer O, Scheibenbogen C, Hanitsch L, Stittrich A, Kolsch U Clin Exp Med. 2023; 23(8):5423-5432.

PMID: 37670184 PMC: 10725337. DOI: 10.1007/s10238-023-01166-2.


Intravenous Immunoglobulins Promote an Expansion of Monocytic Myeloid-Derived Suppressor Cells (MDSC) in CVID Patients.

Simon-Fuentes M, Sanchez-Ramon S, Fernandez-Paredes L, Alonso B, Guevara-Hoyer K, Vega M J Clin Immunol. 2022; 42(5):1093-1105.

PMID: 35486340 PMC: 9053130. DOI: 10.1007/s10875-022-01277-7.


Targeted Proteomics Reveals Inflammatory Pathways that Classify Immune Dysregulation in Common Variable Immunodeficiency.

Berbers R, Drylewicz J, Ellerbroek P, van Montfrans J, Dalm V, van Hagen P J Clin Immunol. 2020; 41(2):362-373.

PMID: 33190167 PMC: 7858548. DOI: 10.1007/s10875-020-00908-1.


References
1.
Yel L . Selective IgA deficiency. J Clin Immunol. 2010; 30(1):10-6. PMC: 2821513. DOI: 10.1007/s10875-009-9357-x. View

2.
Ibanez C, Sune P, Fierro A, Rodriguez S, Lopez M, Alvarez A . Modulating effects of intravenous immunoglobulins on serum cytokine levels in patients with primary hypogammaglobulinemia. BioDrugs. 2005; 19(1):59-65. DOI: 10.2165/00063030-200519010-00007. View

3.
Malphettes M, Gerard L, Carmagnat M, Mouillot G, Vince N, Boutboul D . Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis. 2009; 49(9):1329-38. DOI: 10.1086/606059. View

4.
Ancuta P, Kamat A, Kunstman K, Kim E, Autissier P, Wurcel A . Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One. 2008; 3(6):e2516. PMC: 2424175. DOI: 10.1371/journal.pone.0002516. View

5.
Perneger T . What's wrong with Bonferroni adjustments. BMJ. 1998; 316(7139):1236-8. PMC: 1112991. DOI: 10.1136/bmj.316.7139.1236. View